NCT06471465 Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases Status RECRUITING Phase PHASE3
NCT06466720 Measuring and Mapping Cognitive Decline After Brain Radiosurgery Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06457906 SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC Status RECRUITING Phase PHASE3
NCT06410040 A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06405256 Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases Status RECRUITING Phase N/A
NCT06322342 Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent Status COMPLETED Phase PHASE2
NCT06318065 Surgical Resection Outcomes in Patients With Brain Metastasis Status RECRUITING Phase N/A
NCT06315010 REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis Status RECRUITING Phase PHASE2
NCT06282874 Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06243003 WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases Status RECRUITING Phase PHASE1/PHASE2
NCT06238882 Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. Status RECRUITING Phase NA
NCT06209567 A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT06194929 Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma Status RECRUITING Phase PHASE1/PHASE2
NCT06132945 A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06101069 Development of MRF for Characterization of Brain Tumors After Radiotherapy Status RECRUITING Phase NA
NCT06088056 A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases Status NOT_YET_RECRUITING Phase PHASE2
NCT06072807 Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer Status RECRUITING Phase PHASE4
NCT06055790 Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis Status RECRUITING Phase PHASE2